RMDNYSESurgical & Medical Instruments & ApparatusFiscal year ends June 30Also trades as RSMDF
RESMED INC
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Aug 13, 2026
$239.77+0.80 (+0.33%)
Close on Oct 19, 2026
- Market cap
- $34.79B
- P/E (TTM)
- 23.0
- Dividend yield
- 1.00%
RESMED INC revenue by segment
By business segment
| Revenue | Q4 26 | Q3 26 | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sleep and Breathing Health | $1.29B | $1.26B | $1.26B | $1.17B | $1.18B | $1.13B | $1.13B | $1.07B | $1.07B | $1.05B | $1.02B | $963.04M | 88.3% | +9.4% |
| Residential Care Software | $171.92M | $170.89M | $166.87M | $166.14M | $167.01M | $161.16M | $156.50M | $156.77M | $151.94M | $147.96M | $144.95M | $139.28M | 11.7% | +2.9% |
| Software as a Service | – | – | – | – | – | – | – | – | – | $147.96M | $144.95M | $139.28M | – | – |
| Sleep and Respiratory Care | – | – | – | – | – | – | – | – | $1.07B | $1.05B | $1.02B | $963.04M | – | – |
| Operating income | Q4 26 | Q3 26 | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sleep and Breathing Health | $526.62M | $575.41M | $571.85M | $530.62M | $519.89M | $494.80M | $488.72M | $460.98M | $441.29M | $456.18M | $409.14M | $374.74M | +1.3% |
| Residential Care Software | $55.42M | $58.24M | $50.05M | $54.02M | $55.32M | $53.18M | $48.88M | $47.62M | $42.60M | $38.75M | $41.79M | $31.30M | +0.2% |
| Software as a Service | – | – | – | – | – | – | – | – | – | $38.75M | $41.79M | $31.26M | – |
| Sleep and Respiratory Care | – | – | – | – | – | – | – | – | $441.29M | $456.18M | $426.39M | $390.42M | – |
By product or service
| Revenue | Q4 26 | Q3 26 | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sleep and Breathing Health | $1.29B | $1.26B | $1.26B | $1.17B | $1.18B | $1.13B | $1.13B | $1.07B | $1.07B | $1.05B | $1.02B | $963.04M | 88.3% | +9.4% |
| Residential Care Software | $171.92M | $170.89M | $166.87M | $166.14M | $167.01M | $161.16M | $156.50M | $156.77M | $151.94M | $147.96M | $144.95M | $139.28M | 11.7% | +2.9% |
| Sleep and Respiratory Care | – | – | – | – | – | – | – | – | $1.07B | $1.05B | $1.02B | $963.04M | – | – |
| Software as a Service | – | – | – | – | – | – | – | – | – | $147.96M | $144.95M | $139.28M | – | – |
By region
| Revenue | Q4 26 | Q3 26 | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Global revenue | – | $1.43B | $1.42B | $1.34B | – | $1.29B | $1.28B | $1.22B | $1.22B | $1.20B | $1.16B | $1.10B | – | – |
| Combined Europe, Asia and other markets | – | $441.84M | $420.91M | $394.69M | – | $381.26M | $376.64M | $360.43M | – | $361.55M | $348.53M | $324.68M | – | – |
| U.S., Canada and Latin America | – | $818.67M | $835.03M | $774.75M | – | $749.32M | $748.95M | $707.31M | – | $687.47M | $669.33M | $638.36M | – | – |
From the segment and revenue-disaggregation notes of Resmed's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.